United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - buprenorphine hydrochloride - sublingual tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - buprenorphine hydrochloride - sublingual tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - buprenorphine hydrochloride - sublingual tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - buprenorphine hydrochloride - sublingual tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - buprenorphine hydrochloride - sublingual tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

necessity supplies ltd - buprenorphine hydrochloride - sublingual tablet - 2mg

Israel - English - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride - tablets sublingual - buprenorphine as hydrochloride 8 mg - buprenorphine - buprenorphine - substitution treatment for opioid dependence within a framework of medical, social and psychological treatment.

Israel - English - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride - tablets sublingual - buprenorphine as hydrochloride 2 mg - buprenorphine - buprenorphine - substitution treatment for opioid dependence within a framework of medical, social and psychological treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

indivior pty ltd - buprenorphine hydrochloride, quantity: 17.28 mg (equivalent: buprenorphine, qty 16 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; citric acid; magnesium stearate; crospovidone; acesulfame potassium; flavour - for the treatment of opiate dependence, including maintenance and detoxification, within a framework of medical, social and psychological treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

indivior pty ltd - buprenorphine hydrochloride, quantity: 8.64 mg (equivalent: buprenorphine, qty 8 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; citric acid; magnesium stearate; crospovidone; acesulfame potassium; flavour - for the treatment of opiate dependence, including maintenance and detoxification, within a framework of medical, social and psychological treatment.